首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5010篇
  免费   111篇
  国内免费   17篇
管理学   171篇
民族学   17篇
人才学   1篇
人口学   35篇
丛书文集   100篇
理论方法论   43篇
综合类   719篇
社会学   51篇
统计学   4001篇
  2024年   14篇
  2023年   29篇
  2022年   26篇
  2021年   46篇
  2020年   81篇
  2019年   147篇
  2018年   179篇
  2017年   311篇
  2016年   136篇
  2015年   132篇
  2014年   161篇
  2013年   1440篇
  2012年   520篇
  2011年   151篇
  2010年   147篇
  2009年   145篇
  2008年   147篇
  2007年   123篇
  2006年   119篇
  2005年   133篇
  2004年   102篇
  2003年   94篇
  2002年   112篇
  2001年   90篇
  2000年   63篇
  1999年   75篇
  1998年   68篇
  1997年   53篇
  1996年   35篇
  1995年   35篇
  1994年   29篇
  1993年   23篇
  1992年   24篇
  1991年   18篇
  1990年   16篇
  1989年   14篇
  1988年   13篇
  1987年   9篇
  1986年   5篇
  1985年   13篇
  1984年   13篇
  1983年   16篇
  1982年   6篇
  1981年   2篇
  1980年   5篇
  1979年   8篇
  1978年   2篇
  1977年   2篇
  1976年   2篇
  1975年   2篇
排序方式: 共有5138条查询结果,搜索用时 64 毫秒
41.
One of the main aims of early phase clinical trials is to identify a safe dose with an indication of therapeutic benefit to administer to subjects in further studies. Ideally therefore, dose‐limiting events (DLEs) and responses indicative of efficacy should be considered in the dose‐escalation procedure. Several methods have been suggested for incorporating both DLEs and efficacy responses in early phase dose‐escalation trials. In this paper, we describe and evaluate a Bayesian adaptive approach based on one binary response (occurrence of a DLE) and one continuous response (a measure of potential efficacy) per subject. A logistic regression and a linear log‐log relationship are used respectively to model the binary DLEs and the continuous efficacy responses. A gain function concerning both the DLEs and efficacy responses is used to determine the dose to administer to the next cohort of subjects. Stopping rules are proposed to enable efficient decision making. Simulation results shows that our approach performs better than taking account of DLE responses alone. To assess the robustness of the approach, scenarios where the efficacy responses of subjects are generated from an E max model, but modelled by the linear log–log model are also considered. This evaluation shows that the simpler log–log model leads to robust recommendations even under this model showing that it is a useful approximation to the difficulty in estimating E max model. Additionally, we find comparable performance to alternative approaches using efficacy and safety for dose‐finding. Copyright © 2015 John Wiley & Sons, Ltd.  相似文献   
42.
We consider the problem of variable selection in high-dimensional partially linear models with longitudinal data. A variable selection procedure is proposed based on the smooth-threshold generalized estimating equation (SGEE). The proposed procedure automatically eliminates inactive predictors by setting the corresponding parameters to be zero, and simultaneously estimates the nonzero regression coefficients by solving the SGEE. We establish the asymptotic properties in a high-dimensional framework where the number of covariates pn increases as the number of clusters n increases. Extensive Monte Carlo simulation studies are conducted to examine the finite sample performance of the proposed variable selection procedure.  相似文献   
43.
Generalized linear models (GLMs) have been used widely for modeling the mean response both for discrete and continuous random variables with an emphasis on categorical response. Recently Yang, Mandal and Majumdar (2013 Yang, J., Mandal, A., Majumdar, D. (2013). Optimal designs for 2k factorial experiments with binary response. Technical Report, Available at: http://arxiv.org/pdf/1109.5320v4.pdf. [Google Scholar]) considered full factorial and fractional factorial locally D-optimal designs for binary response and two-level experimental factors. In this article, we extend their results to a general setup with response belonging to a single-parameter exponential family and for multilevel predictors.  相似文献   
44.
45.
In this work, we develop a method of adaptive non‐parametric estimation, based on ‘warped’ kernels. The aim is to estimate a real‐valued function s from a sample of random couples (X,Y). We deal with transformed data (Φ(X),Y), with Φ a one‐to‐one function, to build a collection of kernel estimators. The data‐driven bandwidth selection is performed with a method inspired by Goldenshluger and Lepski (Ann. Statist., 39, 2011, 1608). The method permits to handle various problems such as additive and multiplicative regression, conditional density estimation, hazard rate estimation based on randomly right‐censored data, and cumulative distribution function estimation from current‐status data. The interest is threefold. First, the squared‐bias/variance trade‐off is automatically realized. Next, non‐asymptotic risk bounds are derived. Lastly, the estimator is easily computed, thanks to its simple expression: a short simulation study is presented.  相似文献   
46.
Uniformly most powerful Bayesian tests (UMPBTs) are a new class of Bayesian tests in which null hypotheses are rejected if their Bayes factor exceeds a specified threshold. The alternative hypotheses in UMPBTs are defined to maximize the probability that the null hypothesis is rejected. Here, we generalize the notion of UMPBTs by restricting the class of alternative hypotheses over which this maximization is performed, resulting in restricted most powerful Bayesian tests (RMPBTs). We then derive RMPBTs for linear models by restricting alternative hypotheses to g priors. For linear models, the rejection regions of RMPBTs coincide with those of usual frequentist F‐tests, provided that the evidence thresholds for the RMPBTs are appropriately matched to the size of the classical tests. This correspondence supplies default Bayes factors for many common tests of linear hypotheses. We illustrate the use of RMPBTs for ANOVA tests and t‐tests and compare their performance in numerical studies.  相似文献   
47.
48.
In this paper, the limit distribution of the least squares estimator for mildly explosive autoregressive models with strong mixing innovations is established, which is shown to be Cauchy as in the iid case. The result is applied to identify the onset and the end of an explosive period of an econometric time series. Simulations and data analysis are also conducted to demonstrate the usefulness of the result.  相似文献   
49.
The present paper considers the weighted mixed regression estimation of the coefficient vector in a linear regression model with stochastic linear restrictions binding the regression coefficients. We introduce a new two-parameter-weighted mixed estimator (TPWME) by unifying the weighted mixed estimator of Schaffrin and Toutenburg [1] and the two-parameter estimator (TPE) of Özkale and Kaç?ranlar [2]. This new estimator is a general estimator which includes the weighted mixed estimator, the TPE and the restricted two-parameter estimator (RTPE) proposed by Özkale and Kaç?ranlar [2] as special cases. Furthermore, we compare the TPWME with the weighted mixed estimator and the TPE with respect to the matrix mean square error criterion. A numerical example and a Monte Carlo simulation experiment are presented by using different estimators of the biasing parameters to illustrate some of the theoretical results.  相似文献   
50.
When there are more than two treatments under comparison, we may consider the use of the incomplete block crossover design (IBCD) to save the number of patients needed for a parallel groups design and reduce the duration of a crossover trial. We develop an asymptotic procedure for simultaneously testing equality of two treatments versus a control treatment (or placebo) in frequency data under the IBCD with two periods. We derive a sample size calculation procedure for the desired power of detecting the given treatment effects at a nominal-level and suggest a simple ad hoc adjustment procedure to improve the accuracy of the sample size determination when the resulting minimum required number of patients is not large. We employ Monte Carlo simulation to evaluate the finite-sample performance of the proposed test, the accuracy of the sample size calculation procedure, and that with the simple ad hoc adjustment suggested here. We use the data taken as a part of a crossover trial comparing the number of exacerbations between using salbutamol or salmeterol and a placebo in asthma patients to illustrate the sample size calculation procedure.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号